Aiding gastrointestinal diagnostic laboratory by designing a device for the non invasive detection of peptic ulcer

Mehwish Faiz1, Maheen Murad1, Rabia Khalid1

  • 1Department of Biomedical Engineering, Ziauddin University, Faculty of Engineering, Science, Technology and Management (ZUFESTM), Karachi, Sindh, Pakistan.

Insights

This study introduces a non-invasive device to detect peptic ulcers by monitoring vital signs and saliva pH, aiding in early Helicobacter pylori detection. This method offers a painless alternative to traditional diagnostic procedures.

Area of Science:

  • Gastroenterology
  • Biomedical Engineering
  • Medical Diagnostics

Background:

  • Peptic ulcer disease (PUD) is a significant gastrointestinal issue affecting the stomach and duodenum, often linked to Helicobacter pylori (H. pylori) infection.
  • Current diagnostic methods for PUD are invasive, painful, and not universally accessible.
  • Identifying H. pylori non-invasively is crucial for timely PUD management.

Purpose of the Study:

  • To develop and validate a non-invasive device for detecting peptic ulcers.
  • To identify H. pylori presence by monitoring key physiological parameters.
  • To provide a feasible and accessible diagnostic tool for peptic ulcer disease.

Main Methods:

  • Monitoring respiration rate, heart rate, ECG, saliva pH, and body temperature.
  • Acquiring biosignals as analog input, converting to digital using MCP3008.
  • Processing digital inputs with Raspberry Pi 3 for analysis and output display.

Main Results:

  • Physicochemical parameters like heart rate, temperature, and respiratory rate were observed to elevate.
  • Saliva pH decreased towards the acidic side, and disturbances in the ECG's QRS complex were noted.
  • The device successfully compared obtained parameter values against standard values to determine the presence of peptic ulcers.

Conclusions:

  • The developed non-invasive device effectively identifies peptic ulcers by analyzing physiological changes.
  • Monitoring respiration rate, heart rate, ECG, saliva pH, and temperature offers a reliable method for H. pylori detection.
  • This technology presents a promising, non-invasive alternative for diagnosing peptic ulcer disease.

Related Concept Videos

Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies01:28

Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies

Peptic ulcer disease (PUD) presents with diverse symptoms depending on the location and severity of the ulcer. Clinical manifestations of peptic ulcer include dull pain and a burning sensation in the mid-epigastric region.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
159
Peptic Ulcer Disease IV: Management01:26

Peptic Ulcer Disease IV: Management

Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
115
Peptic Ulcer Disease I: Introduction01:30

Peptic Ulcer Disease I: Introduction

Peptic Ulcer Disease (PUD) is characterized by mucosal excavation in the esophagus, stomach, pylorus, or duodenum. It can manifest as acute or chronic based on the extent and duration of mucosal involvement.
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
215
Acid Suppressive Drugs for Peptic Ulcer Disease: Proton Pump Inhibitors01:13

Acid Suppressive Drugs for Peptic Ulcer Disease: Proton Pump Inhibitors

Peptic ulcers, often induced by H. pylori infections or NSAID usage, arise from disruptions in the delicate balance of gastric acid production. Peptic ulcers stem from heightened gastric acid levels due to H. pylori infections or NSAID use. The protective mucus layer diminishes in the presence of these factors, allowing gastric acid to erode the stomach lining and form ulcers.
Gastric acid, a potent cocktail of hydrogen and chloride ions, is produced in specialized parietal cells within the...
474
Pathophysiology of Peptic Ulcer Disease: Injurious Factors01:22

Pathophysiology of Peptic Ulcer Disease: Injurious Factors

Peptic ulcers are sores on the stomach's inner lining and the upper small intestine, which are the result of disruptions in the mucosal layer that houses parietal cells which produce gastric acid, and chief cells which secrete pepsinogen.
In the antrum region, G cells secrete the gastrin hormone that binds to gastrin-cholecystokinin-B (CCK2) receptors on parietal and enterochromaffin-like (ECL) cells in the fundic glands. Simultaneously, the vagus nerve releases acetylcholine, which binds...
646
Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents01:20

Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents

The gastric mucosa produces prostaglandins E2 (PGE2) and prostacyclin (PGI2), crucial in maintaining gastric health. They exert cytoprotective effects, including increasing bicarbonate secretion, releasing protective mucin, reducing gastric acid output, and preventing harmful vasoconstriction. These effects are mediated through various receptors, such as EP1, EP2, EP3, and EP4.
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
508